Aerpio Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference

CINCINNATI--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will present at the Stifel 2018 Healthcare Conference on Wednesday, November 14, 2018 at 8:00 a.m. Eastern Time in New York, NY. Dr. Hoffman will provide a corporate overview and business update. The presentation will

Full Story →